Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

NAD+ has been studied since 1906. It has 2 Nobel Prizes, randomized human trials, and over a century of biochemistry behind it. Yet in 2017, the FDA advisory committee voted against adding it to the 503A bulks list. The reason wasn't what most people think.

45,084 Aufrufe • vor 1 Monat •via X (Twitter)

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos